Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Aug '25 Aug 5, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Market Capitalization	976	1,064	512	-	-	-	Upgrade
Market Cap Growth	107.98%	107.98%	-	-	-	-	Upgrade
Enterprise Value	822	995	435	-	-	-	Upgrade
Last Close Price	5.42	5.91	2.84	-	-	-	Upgrade
PE Ratio	86.91	89.33	7.83	-	-	-	Upgrade
Forward PE	14.69	15.80	-	-	-	-	Upgrade
PS Ratio	5.08	5.54	1.81	-	-	-	Upgrade
PB Ratio	2.55	2.78	1.40	-	-	-	Upgrade
P/TBV Ratio	2.55	2.78	1.40	-	-	-	Upgrade
EV/Sales Ratio	4.54	5.18	1.54	-	-	-	Upgrade
EV/EBITDA Ratio	42.74	55.81	6.98	-	-	-	Upgrade
EV/EBIT Ratio	51.94	61.37	7.07	-	-	-	Upgrade
Debt / Equity Ratio	0.44	0.44	0.28	0.26	4.55	3.52	Upgrade
Debt / EBITDA Ratio	8.44	8.44	1.61	-	-	-	Upgrade
Asset Turnover	0.22	0.22	0.54	0.20	-	-	Upgrade
Inventory Turnover	0.38	0.38	0.83	0.21	0	0	Upgrade
Quick Ratio	2.11	2.11	9.04	4.84	22.79	6.47	Upgrade
Current Ratio	4.07	4.07	13.98	14.78	262.76	45.18	Upgrade
Return on Equity (ROE)	3.16%	3.16%	22.29%	-3.45%	-91.82%	-35.95%	Upgrade
Return on Assets (ROA)	1.15%	1.15%	7.40%	-1.56%	-2.25%	-2.69%	Upgrade
Return on Capital (ROIC)	1.98%	1.98%	10.31%	-2.63%	-3.82%	-3.23%	Upgrade
Return on Capital Employed (ROCE)	1.80%	1.80%	10.90%	-	-	-	Upgrade
Earnings Yield	1.22%	1.12%	12.77%	-	-	-	Upgrade
FCF Yield	-9.93%	-9.10%	-4.31%	-	-	-	Upgrade
Buyback Yield / Dilution	-	-	91.96%	-746403.64%	-	-	Upgrade

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.